Even though c-Kit is overexpressed in SCLC cell lines, naked antibodies cannot be applied to treat SCLC because of the limited contribution of SCF/c-Kit signaling in the pathogenesis of SCLC and failure of imatinib [32,33]. This evidence concerns the gene KITLG and small cell lung carcinoma.